The Patent Finder

Bearsden Bio, Inc.

Also on record
Records under this name other than patents Bearsden Bio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Bearsden Bio, Inc.

PatentTitleStatus Expires Confidence
US 6,107,029Universal method for detecting interactions between RNA molecules and RNA binding proteins
Formerly held
Lapsed on the fee record
Ended Aug 22, 2012 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2012From the USPTO record
US 6,048,8531-arylphthalazine antagonists of excitatory amino acid receptors
Formerly held
Lapsed on the fee record
Ended Apr 11, 2012 · From the USPTO record
Lapsed on the fee recordEnded Apr 11, 2012From the USPTO record
US 6,511,963Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
Lapsed on the fee record
Ended Jan 28, 2007 · From the USPTO record
Lapsed on the fee recordEnded Jan 28, 2007From the USPTO record
US 6,284,731Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
Lapsed on the fee record
Ended Sep 4, 2005 · From the USPTO record
Lapsed on the fee recordEnded Sep 4, 2005From the USPTO record
US 6,110,894Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
Lapsed on the fee record
Ended Aug 29, 2004 · From the USPTO record
Lapsed on the fee recordEnded Aug 29, 2004From the USPTO record
US 5,716,956Dihydrophthalazine antagonists of excitatory amino acid receptors
Formerly held
Term ended
Term ended no later than Feb 10, 2018 · Low confidence
Term endedTerm ended no later than Feb 10, 2018Low confidence
US 5,731,348Alkylcarboxy amino acids-modulators of the kainate receptor
Term ended
Term ended no later than Mar 24, 2018 · Low confidence
Term endedTerm ended no later than Mar 24, 2018Low confidence
US 5,830,998Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
Term ended
Term ended no later than Nov 3, 2018 · Low confidence
Term endedTerm ended no later than Nov 3, 2018Low confidence
US 5,854,217Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
Term ended
Term ended no later than Dec 29, 2018 · Low confidence
Term endedTerm ended no later than Dec 29, 2018Low confidence
US 5,859,227RNA sequences which interact with RNA-binding proteins
Formerly held
Term ended
Term ended no later than Jan 12, 2019 · Low confidence
Term endedTerm ended no later than Jan 12, 2019Low confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited